Rights and permissions
About this article
Cite this article
FDA aims for neutral tone in drug-rejection letters. Nature 454, 265 (2008). https://doi.org/10.1038/454265e
Published:
Issue Date:
DOI: https://doi.org/10.1038/454265e
- Springer Nature Limited